TP53 and cancer: Alternatively, because BRCA1 genes are also involved in the G2-M and spindle assembly checkpoints, loss of heterozygosity at the TP53 locus might occur more efficiently in BRCA1-deficient cells (29).The variant of TP53 increase the lifetime risk of developing cancer to 75% in males and almost 100% in females (30).